86-21-64556180 ib

FXR

CAT # Khoom npe Kev piav qhia
PAB 9470 Obeticholic-Acid Obeticholic Acid (INT747; 6-ECDCA) yog ib qho tshiab derivative ntawm cholic acid uas ua raws li lub zog thiab xaiv FXR agonist nthuav tawm cov kev ua haujlwm anticholeretic hauv vivo nas qauv ntawm cholestasis. Nws inhibits vascular du leeg cell o thiab tsiv teb tsaws thiab txhawb nqa adipocytes sib txawv thiab tswj adipose cell muaj nuj nqi hauv vivo.
PAB 100579 fexaramine Fexaramine yog ib qho agonist ntawm farnesoid X receptor (FXR), uas yog cov kua tsib acid-activated nuclear receptor uas tswj cov kua tsib-acid synthesis, conjugation thiab thauj, nrog rau lipid metabolism los ntawm kev ua hauv daim siab thiab txoj hnyuv. Fexaramine muaj 100-fold ntau dua affinity rau FXR dua li tej yam ntuj tso tebchaw thiab piav txog lub hom phiaj genomic thiab khi qhov chaw ntawm FXR. Thaum muab tshuaj rau cov nas, fexaramine tsim cov kev xaiv los ntawm FXR receptors hauv cov hnyuv.
PAB 100577 Lithocholic-acid Levallorphan, tseem hu ua levallorphan tartate (USAN), yog opioid modulator ntawm tsev neeg morphinan siv los ua opioid analgesic thiab opioid antagonist / antidote. Nws ua raws li tus antagonist ntawm μ-opioid receptor (MOR) thiab ua tus agonist ntawm κ-opioid receptor (KOR), thiab vim li ntawd, thaiv cov teebmeem ntawm cov neeg ua haujlwm muaj zog nrog ntau dua cov haujlwm hauv lub cev xws li morphine thaum lub sijhawm ua kom muaj kev ua xua. . Raws li tus agonist ntawm KOR, levallorphan tuaj yeem ua rau muaj kev puas siab puas ntsws loj ntawm cov koob tshuaj txaus suav nrog kev hnov ​​​​lus, kev tsis sib haum xeeb, thiab lwm yam kev puas siab puas ntsws, dysphoria, ntxhov siab, tsis meej pem, kiv taub hau, disorientation, derealization, kev xav qaug dej qaug cawv, thiab txawv txawv, txawv txawv, lossis kev npau suav phem. . (Source: https://en.wikipedia.org/wiki/Levallorphan).
PIB 100575 Turofexorate-Isopropyl Turofexorate isopropyl, tseem hu ua WAY-362450 thiab XL335, yog lub zog muaj zog, xaiv, thiab hais lus nquag agonist ntawm farnesoid X receptor (FXR) (EC(50) = 4 nM, Eff = 149%), uas ua rau lub siab mob. thiab fibrosis hauv murine qauv ntawm non-alcoholic steatohepatitis
PIB 100574 wb 4064 GW4064是一种farnesoid X receptor (FXR) 激动剂,CV1细胞系中EC50为65 nM。浓度达到1 μM时,对其有核受体
PAB 1549 Tropifexor Tropifexor yog ib qho tshiab thiab muaj zog agonist ntawm FXR nrog EC50 ntawm 0.2 nM.
ua

Tiv tauj peb

Kev nug

Xov xwm tshiab

  • Sab saum toj 7 trends hauv Pharmaceutical Research Hauv 2018

    Sab saum toj 7 Trends Hauv Pharmaceutical Research Kuv ...

    Nyob rau hauv ib txwm muaj-nce siab los sib tw nyob rau hauv ib tug nyuaj kev lag luam thiab thev naus laus zis ib puag ncig, kws tshuaj thiab biotech tuam txhab uas muag yuav tsum txuas ntxiv innovate nyob rau hauv lawv cov R & D cov kev pab cuam nyob rau hauv ...

  • ARS-1620: Kev cog lus tshiab inhibitor rau KRAS-mutant qog noj ntshav

    ARS-1620: Kev cog lus tshiab inhibitor rau K ...

    Raws li kev tshawb fawb luam tawm hauv Cell, cov kws tshawb fawb tau tsim ib qho inhibitor tshwj xeeb rau KRASG12C hu ua ARS-1602 uas ua rau cov qog nqaij hlav hauv cov nas. "Qhov kev tshawb fawb no muab pov thawj hauv vivo tias mutant KRAS tuaj yeem yog ...

  • AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau cov tshuaj oncology

    AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau ...

    AstraZeneca tau txais kev txhawb nqa ob npaug rau nws cov ntaub ntawv kho mob oncology rau hnub Tuesday, tom qab Asmeskas thiab European cov neeg tswj hwm tau txais kev tswj hwm kev xa tawm rau nws cov tshuaj, thawj kauj ruam ntawm kev pom zoo rau cov tshuaj no. ...

WhatsApp pawg online sib tham!